home / stock / orpof / orpof short
Short Information | OSE Immunotherapeutics SA (OTCMKTS:ORPOF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 10,120 |
Total Actual Volume | 10,120 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 3 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 506 |
Average Short Percentage | 15.00% |
Is there a ORPOF Short Squeeze or Breakout about to happen?
See the ORPOF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-26-2019 | $4.00 | $4.00 | $4.00 | $4.00 | 120 | 120 | 100% |
06-13-2019 | $N/A | $4.75 | $N/A | $N/A | 5,000 | 5,000 | 100% |
04-04-2019 | $4.75 | $4.75 | $4.75 | $4.75 | 5,000 | 5,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
OSE Immunotherapeutics SA Company Name:
ORPOF Stock Symbol:
OTCMKTS Market:
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371 Ingelheim, Germany and Nantes, France, 3 July 2024 – Today Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage ...
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’ Nantes, France – July 1 st , 2024 – 7:30 am CET – OSE Immunotherapeutics SA (ISIN: FR...
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell Therapies NANTES, France, June 24, 2024 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , today announced that the Company has entered into a commercial ...